Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Bruscaggin

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|May 11, 2012
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndromeDavide Rossi, Silvia Rasi, Valeria Spina, et al.
Haematologica|January 29, 2016
Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemiaSilvia Rasi, Hossein Khiabanian, Carmela Ciardullo, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Leukemia & Lymphoma|October 9, 2012
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemiaLorenzo De Paoli, Michaela Cerri, Sara Monti, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
Blood Advances|September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumabAlessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
Haematologica|February 24, 2018
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasiasBernhard Gerber, Martina Manzoni, Valeria Spina, et al.
British Journal of Haematology|December 3, 2010
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndromeSilvia Rasi, Valeria Spina, Alessio Bruscaggin, et al.
Haematologica|May 9, 2024
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapyChiara Tarantelli, David Wald, Nicolas Munz, et al.
Blood|November 15, 2011
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Giulia Fabbri, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|May 11, 2012
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndromeDavide Rossi, Silvia Rasi, Valeria Spina, et al.
Haematologica|January 29, 2016
Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemiaSilvia Rasi, Hossein Khiabanian, Carmela Ciardullo, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Leukemia & Lymphoma|October 9, 2012
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemiaLorenzo De Paoli, Michaela Cerri, Sara Monti, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
Blood Advances|September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumabAlessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
Haematologica|February 24, 2018
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasiasBernhard Gerber, Martina Manzoni, Valeria Spina, et al.
British Journal of Haematology|December 3, 2010
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndromeSilvia Rasi, Valeria Spina, Alessio Bruscaggin, et al.
Haematologica|May 9, 2024
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapyChiara Tarantelli, David Wald, Nicolas Munz, et al.
Blood|November 15, 2011
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Giulia Fabbri, et al.
Pageof 5